| ACE2 | angiotensin-converting enzyme 2 |
| Af-CAR | Aspergillus fumigatus-specific chimeric antigen receptor |
| AIDS | acquired immunodeficiency syndrome |
| allo-HCT | allogeneic hematopoietic cell transplantation |
| ART | antiretroviral therapy |
| BNAb | broadly neutralizing antibody |
| CAR | chimeric antigen receptor |
| cccDNA | covalently closed circular DNA |
| CMV | cytomegalovirus |
| COVID-19 | Coronavirus disease-19 |
| CRS | cytokine release syndrome |
| CXCR5 | C-X-C chemokine receptor type 5 |
| D-CAR | chimeric antigen receptor targeting Dectin-1 receptor |
| DNA | deoxyribonucleic acid |
| E2 | E2 glycoprotein |
| EBNA | Epstein–Barr nuclear antigen |
| EBV | Epstein–Barr virus |
| EGFRt | truncated epidermal growth factor receptor |
| Fc | crystallizable fragment |
| gp350 | glycoprotein 350 |
| gp120 | glycoprotein 120 |
| GXM | glucuronoxylomannan |
| GXMR-CAR | glucuronoxylomannan-specific chimeric antigen receptor |
| HBsAg | hepatitis B surface antigen |
| HBV | hepatitis B virus |
| HCV | hepatitis C virus |
| HIV | human immunodeficiency virus |
| HSV-TK | herpes simplex virus thymidine kinase |
| iC9 | inducible caspase 9 |
| IFDs | invasive fungal diseases |
| IFN-γ | interferon-γ |
| IL-12 | interleukin-12 |
| IL-2 | interleukin-2 |
| IPA | invasive pulmonary aspergillosis |
| L | large surface proteins |
| LMP1 | latent membrane protein 1 |
| MERTK | Mer tyrosine kinase |
| NK | natural killer |
| PTLD | post-transplant lymphoproliferative disease |
| RBD | receptor-binding domain |
| RNA | ribonucleic acid |
| S | small surface proteins |
| S1 | spike protein |
| scFv | functional single-chain variable fragment |
| TCR | T-cell receptor |
| TNF-a | tumor necrosis factor-α |
| TRUCKs | T cells capable of universal cytokine-mediated killing |